Gyre Therapeutics, Inc. SEC filings GYRE
Gyre Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Sep 10, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Oct 26, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 2, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 2, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 2, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 11, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 3, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 4, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 5, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 5, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Jul 31, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 7, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 6, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 7, 2014 | Jun 30, 2014 |
| 10-Q/A | Amended quarterly report | Jun 9, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | May 8, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 6, 2013 | Sep 30, 2013 |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC. (until Oct 27, 2023); TARGACEPT INC (until Aug 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.